Efficacy and Safety of Intravitreal Conbercept With Modified Treat-and-Extend Regimens in Exudative Age-Related Macular Degeneration
Latest Information Update: 19 Sep 2022
At a glance
- Drugs Conbercept (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- Acronyms IIT-A
- 19 Sep 2022 New trial record